CARDIO DIAGNOSTICS HOLDINGS
CDIONASDAQTrading Snapshot
- Day Range
- $1.54 β $1.61
- 52-Week Range
- $0.97 β $7.91
- Volume (shares)
- 32,032
- Avg Volume (shares)
- β
- Shares Outstanding
- 3.0M
- Next Earnings
- 2027-03-03
Fundamentals Snapshot
- Annual Revenue
- $14,825
- Last Q Revenue
- $3,590
- P/E Ratio
- -0.6
- P/S Ratio
- 311.8x
- EPS (TTM)
- $-2.19
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β96.0%
CARDIO DIAGNOSTICS HOLDINGS
CDIOAbout CARDIO DIAGNOSTICS HOLDINGS
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates

Cardio Diagnostics to Unveil Non-Obstructive Coronary Artery Disease Data, FDA Breakthrough Device Designation Strategy, and India Launch Update on December 10 Investor Call
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. will host an investor conference call on Thursday, December 10, 2026, at 11 a.m. Central Time.

Cardio Diagnostics' Whitepaper Examines Clinical Blind Spot in Coronary Heart Disease Detection and Care
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics released a new whitepaper as a resource for clinicians navigating current limitations in detecting and managing NOCAD.

Critical Analysis: Genmab A/S (NASDAQ:GMAB) versus Cardio Diagnostics (NASDAQ:CDIO)
Genmab A/S (NASDAQ: GMAB - Get Free Report) and Cardio Diagnostics (NASDAQ: CDIO - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the stren

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Shares Shorted: Short Interest Down 77.7% in September
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO - Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totaling 5,259 shares, a drop of 77.7% from

Cardio Diagnostics Holdings, Inc. (CDIO) Shareholder/Analyst Call Prepared Remarks Transcript
Cardio Diagnostics Holdings, Inc. (CDIO) Shareholder/Analyst Call Prepared Remarks Transcript

Cardio Diagnostics (NASDAQ:CDIO) & Sutro Biopharma (NASDAQ:STRO) Head-To-Head Analysis
Sutro Biopharma (NASDAQ: STRO - Get Free Report) and Cardio Diagnostics (NASDAQ: CDIO - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses b